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We report the first whole-genome sequence for a clinical isolate of Staphylococcus pseudintermedius (ED99),
the major pathogen responsible for canine bacterial pyoderma. S. pseudintermedius contains numerous mobile
genetic elements and encodes an array of putative virulence factors, including superantigenic, cytolytic, and
exfoliative toxins and cell wall-associated surface proteins.
Staphylococcus pseudintermedius is a resident of the skin and
mucosal surfaces of most healthy dogs (5). However, disrup-
tion of the normal skin flora, damage to the cutaneous barrier
by a pruritic condition, immunosuppression, or inherent im-
munodeficiency can lead to surface, superficial, or deep pyo-
derma (9). Furthermore, S. pseudintermedius occasionally
causes severe human zoonotic infections (8), and isolates ex-
hibit various degrees of antimicrobial resistance (6).
Whole-genome sequencing of a representative S. pseud-
intermedius strain (ED99) (1) was carried out with two runs
using the Genome Sequencer FLX sequencer, generating a
total of 350,290 reads with an average length of 257 bases,
corresponding to more than 32.5 genome coverage. As-
sembly with 454 Newbler software (454 Life Sciences, Bran-
ford, CT) resulted in a total of 65 contigs with an N50 value
of 85,670 bases. Gaps between contigs were filled by con-
ventional or combinatorial PCR and use of the GPS-1 ge-
nome priming system (New England BioLabs), followed by
sequencing with an ABI 3730 capillary sequencer. Final
assembly, annotation, and genome analysis were carried out
as previously described (4). The genome of S. pseudinterme-
dius ED99 is composed of a single circular chromosome of
2,572,216 bp and has an average GC content of 37.6%,
which is substantially higher than the 32% average of other
staphylococci (2). It contains five ribosomal operons and 58
tRNA loci and encodes 2,401 predicted protein-coding se-
quences (CDSs). S. pseudintermedius ED99 contains numer-
ous predicted mobile genetic elements, including insertion
elements, transposons mediating resistance to antibiotics, a
remnant of a novel member of the staphylococcal pathoge-
nicity island family (SaPI), a family of reverse transcriptase
(RT) group II introns, and a putative integrated plasmid. S.
pseudintermedius ED99 also contains a type Nmeni CRISPr
locus, which includes 23 predicted spacer regions.
S. pseudintermedius encodes a number of predicted toxins,
including the superantigen Se-int (3), the bicomponent leu-
kotoxin Luk-I (7), the exfoliative toxin SIET (10), and ho-
mologs of hemolysin III and -hemolysin. In addition, we
identified a putative novel exfoliative toxin and numerous
exoenzymes, including lipases, a thermonuclease, a thermo-
lysin, and an array of proteases, including a group of eight
predicted glutamyl-endopeptidases.
S. pseudintermedius ED99 contains at least 18 genes spe-
cific for predicted cell wall-associated proteins and encodes
numerous global regulators characteristic of other staphy-
lococcal species, including agr, sar, sae, and rot.
Overall, the genome sequence of a strain of S. pseudin-
termedius represents an important framework for investiga-
tions into the molecular pathogenesis of canine bacterial
pyoderma.
Nucleotide sequence accession number. The complete ge-
nome sequence of S. pseudintermedius ED99 has been depos-
ited in the GenBank database with the accession number
CP002478.
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